Current Cell-Based Therapies in the Chronic Liver Diseases
Author:
Publisher
Springer Japan
Link
http://link.springer.com/content/pdf/10.1007/978-4-431-56847-6_13
Reference50 articles.
1. Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I et al (2016) Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol 51(7):629–650
2. Naggie S, Muir AJ (2017) Oral combination therapies for hepatitis C virus infection: successes, challenges, and unmet needs. Annu Rev Med 68:345–358
3. Forbes SJ, Newsome PN (2012) New horizons for stem cell therapy in liver disease. J Hepatol 56(2):496–499
4. Terai S, Tsuchiya A (2017) Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis. J Gastroenterol 52(2):129–140
5. Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H et al (2018) The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial. Hepatology 67(2):549–559
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cell-based treatment for perinatal hypoxic-ischemic encephalopathy;Brain Circulation;2021
2. Cell-Based Therapy for Stroke;Stroke;2020-09
3. Ultrasound-targeted microbubble destruction optimized HGF-overexpressing bone marrow stem cells to repair fibrotic liver in rats;Stem Cell Research & Therapy;2020-04-03
4. A Museum of Stem Cells Points to Muse Cells as Robust Transplantable Cells for Stroke: Review;Advances in Experimental Medicine and Biology;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3